MedPath

INFUTRAZE CONCENTRADO PARA SOLUCION PARA PERFUSION

INFUTRAZE CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

88927

Prescription Type

Medicamento Sujeto A Prescripción Médica,Uso Hospitalario

Authorization Date

Jun 27, 2023

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number88927
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (5)

COBRE CLORURO DIHIDRATOActive
Quantity: 107,40 µg
Name: COBRE CLORURO DIHIDRATO
MANGANESO (CLORURO DE) TETRAHIDRATOActive
Quantity: 3,60 µg
Name: MANGANESO (CLORURO DE) TETRAHIDRATO
POTASIO IODUROActive
Quantity: 2,56 µg
Name: POTASIO IODURO
SELENITO SODIO ANHIDROActive
Quantity: 15,33 µg
Name: SELENITO SODIO ANHIDRO
ZINC CLORUROActive
Quantity: 1042 µg
Name: ZINC CLORURO

ATC CLASSIFICATION (3)

B05X
B05XA
B05XA31

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.